What is the difference between Rituxan and Rituxan Hycela?
Key Points
- Rituxan (rituximab) is administered intravenously (IV), while Rituxan Hycela is given subcutaneously (SC).
- Both contain rituximab, but Rituxan Hycela includes hyaluronidase, an enzyme that aids absorption.
- Infusion time differs: Rituxan IV takes several hours, whereas Rituxan Hycela SC takes 5-7 minutes.
Rituxan vs. Rituxan Hycela: Key Differences
Rituxan Hycela (rituximab and hyaluronidase human) includes the same monoclonal antibody as Rituxan (rituximab), but in combination with hyaluronidase, an enzyme that helps to deliver rituximab by subcutaneous injection under the skin. The original Rituxan is given only by intravenous (IV) infusion.
Administration Method
Rituxan Hycela is administered via subcutaneous injection to adults with the following blood cancers:
- follicular lymphoma
- diffuse large B-cell lymphoma (DLBCL)
- chronic lymphocytic leukemia (CLL)
Rituxan is administered via intravenous infusion for the following conditions:
- non-Hodgkin’s lymphoma (including follicular lymphoma and diffuse large B-cell lymphoma)
- chronic lymphocytic leukemia (CLL)
- rheumatoid arthritis
- granulomatosis with polyangiitis (GPA) (Wegener’s Granulomatosis) and
microscopic polyangiitis (MPA) - pemphigus vulgaris
Related questions
- What are the new drugs for rheumatoid arthritis (RA)?
- How soon can you start chemo after port placement?
- What is the difference between Truxima and Rituxan?
Composition
- Both contain rituximab, a monoclonal antibody that targets CD20-positive B cells.
- Rituxan Hycela also contains hyaluronidase, which facilitates drug absorption when injected under the skin.
Treatment time
- Rituxan (IV Infusion): The first infusion takes 4-6 hours, with subsequent doses taking 3-4 hours.
- Rituxan Hycela (SC Injection): Takes approximately 5-7 minutes per dose.
Who Can Receive Rituxan Hycela?
Rituxan Hycela is only for patients who have previously received at least one full IV dose of Rituxan to ensure they tolerate the medication.
Which One Is Right for You?
Clinical studies showed Rituxan Hycela delivered similar blood levels and effectiveness of rituximab; however, the majority (77 percent) of patients preferred Rituxan Hycela over IV Rituxan due to less time spent in the clinic.
Your doctor will determine whether Rituxan or Rituxan Hycela is best based on your medical history, condition, and treatment goals. Rituxan Hycela offers a shorter administration time, but not all patients are eligible for the switch from IV to SC.
Both medications have similar side effects and require monitoring for adverse reactions. Always consult your doctor for personalized medical advice before starting or switching treatments.
This is not all the information you need about Rituxan or Rituxan Hycela. Review the full prescribing information and discuss it with your healthcare provider.
References
- Rituxan Hycela [package insert]. 2024. Genentech, Inc. Accessed March 27, 2025 at https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3e5b7e82-f018-4eaf-ae78-d6145a906b20
- Rituxan [package insert]. 2025. Genentech, Inc. Accessed March 27, 2025 at https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b172773b-3905-4a1c-ad95-bab4b6126563
Read next
What is the success rate of Rituxan (rituximab) in patients with blood cancers?
In patients with hematological or blood cancers, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL), Rituxan’s success is measured in a number of ways. It is measured by looking at how long patients responded to treatment (median duration of response), how long they live without their disease progressing (progression-free survival) and how many patients respond to treatment (response rate).
Rituxan treatment improves outcomes in certain patients with NHL. Adding Rituxan alongside standard therapies enhances the response patients have to treatment and improves overall outcomes, including increasing the time patients live for without experiencing a progression of their disease.
Rituxan helps to improve overall survival in certain patients with CLL and also helps to increase the time patients live for without experiencing disease progression. Adding Rituxan alongside standard therapy enhances the response patients have to therapy. Continue reading
What is a chemotherapy regimen?
A chemotherapy (chemo) regimen consists of anti-cancer medicines you receive over a set period of time (usually over several cycles). Chemo regimens, such as R-CHOP, are often abbreviated by using the first letter of the drug names. For example, R-CHOP is an abbreviation for a 5-drug chemotherapy regimen used to treat non-Hodgkin’s lymphoma, a type of blood cancer.
Continue reading
What is the success rate of Rituxan (rituximab) in rheumatoid arthritis?
Treatment with Rituxan (rituximab) successfully improves patient outcomes in patients with rheumatoid arthritis including reducing symptoms, reducing levels of fatigue and disability, and increasing health-related quality of life. It also slows the progression of structural damage in joints. Continue reading
See also:
Related medical questions
- What causes infusion reactions to rituximab?
- What are biologic drugs and how do they work?
- What biosimilars have been approved in the United States?
- Are lung nodules common after Bendeka & Rituxan therapy?
- How will I feel after a Rituxan infusion?
- What are Monoclonal Antibodies and how do they work?
- How long does it take for Rituxan to work?
- Biosimilars vs Biologics: What are they and how do they compare?
- Does Rituxan cause hair loss?
- How does the drug Rituxan work?
- How do you prepare for a Rituxan infusion?
- How is Rituxan Hycela administered?
Drug information
Related support groups
- Rituximab (13 questions, 56 members)
- Rituxan (21 questions, 105 members)
- Rituxan Hycela (2 questions, 3 members)
- Follicular Lymphoma (21 questions, 15 members)
- Rheumatoid Arthritis (337 questions, 1,333 members)
- Diffuse Large B-Cell Lymphoma (19 questions, 3 members)
- Non-Hodgkin's Lymphoma (18 questions, 39 members)
- Chronic Lymphocytic Leukemia (CLL) (27 questions, 57 members)
- Granulomatosis with Polyangiitis (9 questions, 18 members)
- Pemphigus Vulgaris (4 questions, 4 members)